HEADER TRANSFERASE 31-JAN-03 1J3H TITLE CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC TITLE 2 SUBUNIT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PKAC-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PRSETB KEYWDS APOENZYME, CAMP-DEPENDENT PROTEIN KINASE, CATALYTIC SUBUNIT, OPEN KEYWDS 2 CONFORMATION, PREFORMED ACTIVE SITE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.AKAMINE,MADHUSUDAN,J.WU,N.H.XUONG,L.F.TEN EYCK,S.S.TAYLOR REVDAT 5 30-OCT-24 1J3H 1 REMARK REVDAT 4 25-OCT-23 1J3H 1 REMARK REVDAT 3 04-AUG-21 1J3H 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1J3H 1 VERSN REVDAT 1 04-MAR-03 1J3H 0 JRNL AUTH P.AKAMINE,MADHUSUDAN,J.WU,N.-H.XUONG,L.F.TEN EYCK,S.S.TAYLOR JRNL TITL DYNAMIC FEATURES OF CAMP-DEPENDENT PROTEIN KINASE REVEALED JRNL TITL 2 BY APOENZYME CRYSTAL STRUCTURE JRNL REF J.MOL.BIOL. V. 327 159 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12614615 JRNL DOI 10.1016/S0022-2836(02)01446-8 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH MADHUSUDAN,P.AKAMINE,N.H.XUONG,S.S.TAYLOR REMARK 1 TITL CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE REMARK 1 TITL 2 CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 1 REF NAT.STRUCT.BIOL. V. 9 273 2002 REMARK 1 REFN ISSN 1072-8368 REMARK 1 DOI 10.1038/NSB780 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.KARLSSON,J.ZHENG,N.XUONG,S.S.TAYLOR,J.M.SOWADSKI REMARK 1 TITL STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF REMARK 1 TITL 2 CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE REMARK 1 TITL 3 DISPLAYS AN OPEN CONFORMATION REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 49 381 1993 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444993002306 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.ZHENG,D.R.KNIGHTON,N.H.XUONG,S.S.TAYLOR,J.M.SOWADSKI, REMARK 1 AUTH 2 L.F.TEN EYCK REMARK 1 TITL CRYSTAL STRUCTURES OF THE MYRISTYLATED CATALYTIC SUBUNIT OF REMARK 1 TITL 2 CAMP-DEPENDENT PROTEIN KINASE REVEAL OPEN AND CLOSED REMARK 1 TITL 3 CONFORMATIONS REMARK 1 REF PROTEIN SCI. V. 2 1559 1993 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.ZHENG,D.R.KNIGHTON,L.F.TEN EYCK,R.KARLSSON,N.XUONG, REMARK 1 AUTH 2 S.S.TAYLOR,J.M.SOWADSKI REMARK 1 TITL CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE COMPLEXED WITH MGATP AND PEPTIDE INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 32 2154 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 5 REMARK 1 AUTH N.NARAYANA,S.COX,X.NGUYEN-HUU,L.F.TEN EYCK,S.S.TAYLOR REMARK 1 TITL A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT REMARK 1 TITL 2 PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL REMARK 1 TITL 3 FLEXIBILITY REMARK 1 REF STRUCTURE V. 5 921 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(97)00246-3 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 17054 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 823 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4986 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1J3H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000005583. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JAN-99 REMARK 200 TEMPERATURE (KELVIN) : 97 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : 58CM LONG, PT-COATED, FUSED REMARK 200 SILICA, VERTICAL FOCUSMIRROR, REMARK 200 CYCLINDRICALLY BENT TRIANGULAR REMARK 200 SI(111) ASYMMETRIC CUT, REMARK 200 HORIZONTAL FOCUS MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18822 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : 0.05500 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1CTP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS-HYDROGEN CHLORIDE, MPD, BICINE, REMARK 280 AMMONIUM ACETATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 71.80050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 LYS A 319 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP A 323 REMARK 465 THR A 324 REMARK 465 SER A 325 REMARK 465 ASN A 326 REMARK 465 PHE A 327 REMARK 465 ASP A 328 REMARK 465 GLY B 1 REMARK 465 ASN B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 ALA B 5 REMARK 465 ALA B 6 REMARK 465 LYS B 7 REMARK 465 LYS B 8 REMARK 465 GLY B 9 REMARK 465 SER B 10 REMARK 465 SER B 325 REMARK 465 ASN B 326 REMARK 465 PHE B 327 REMARK 465 ASP B 328 REMARK 465 ASP B 329 REMARK 465 TYR B 330 REMARK 465 GLU B 331 REMARK 465 GLU B 332 REMARK 465 GLU B 333 REMARK 465 GLU B 334 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 10 OG REMARK 470 GLN A 12 CG CD OE1 NE2 REMARK 470 GLU A 13 CG CD OE1 OE2 REMARK 470 SER A 14 OG REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 GLU A 24 CG CD OE1 OE2 REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 ASP A 44 CG OD1 OD2 REMARK 470 ARG A 45 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 46 CD1 REMARK 470 LYS A 47 CG CD CE NZ REMARK 470 THR A 51 OG1 CG2 REMARK 470 VAL A 60 CG1 CG2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 LYS A 63 CG CD CE NZ REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 ILE A 73 CD1 REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LEU A 82 CG CD1 CD2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 ILE A 85 CG1 CG2 CD1 REMARK 470 GLU A 86 CG CD OE1 OE2 REMARK 470 SER A 114 OG REMARK 470 VAL A 119 CG1 CG2 REMARK 470 GLU A 127 CG CD OE1 OE2 REMARK 470 ILE A 135 CD1 REMARK 470 SER A 139 OG REMARK 470 HIS A 142 CG ND1 CD2 CE1 NE2 REMARK 470 SER A 159 OG REMARK 470 VAL A 191 CG1 CG2 REMARK 470 ILE A 210 CD1 REMARK 470 SER A 212 OG REMARK 470 LYS A 213 CG CD CE NZ REMARK 470 ILE A 228 CD1 REMARK 470 PHE A 239 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 242 CG CD OE1 NE2 REMARK 470 GLN A 245 CG CD OE1 NE2 REMARK 470 ILE A 246 CD1 REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 ILE A 250 CG1 CG2 CD1 REMARK 470 SER A 252 OG REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 VAL A 255 CG1 CG2 REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 SER A 263 OG REMARK 470 ARG A 270 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 271 CG OD1 ND2 REMARK 470 VAL A 275 CG1 CG2 REMARK 470 LEU A 277 CG CD1 CD2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 ILE A 291 CD1 REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 ILE A 303 CD1 REMARK 470 LYS A 309 CG CD CE NZ REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 ILE A 315 CD1 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 329 CG OD1 OD2 REMARK 470 TYR A 330 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 332 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ILE A 335 CD1 REMARK 470 ARG A 336 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 337 CG1 CG2 REMARK 470 ILE A 339 CG1 CG2 CD1 REMARK 470 GLU A 341 CG CD OE1 OE2 REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 THR A 348 OG1 CG2 REMARK 470 GLU B 11 CG CD OE1 OE2 REMARK 470 GLN B 12 CG CD OE1 NE2 REMARK 470 GLU B 13 CG CD OE1 OE2 REMARK 470 SER B 14 OG REMARK 470 VAL B 15 CG1 CG2 REMARK 470 LYS B 16 CG CD CE NZ REMARK 470 GLU B 17 CG CD OE1 OE2 REMARK 470 LYS B 21 CG CD CE NZ REMARK 470 ASP B 25 CG OD1 OD2 REMARK 470 LYS B 29 CG CD CE NZ REMARK 470 THR B 37 OG1 CG2 REMARK 470 ARG B 45 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 46 CD1 REMARK 470 LYS B 47 CG CD CE NZ REMARK 470 THR B 51 OG1 CG2 REMARK 470 SER B 53 OG REMARK 470 PHE B 54 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL B 57 CG1 CG2 REMARK 470 LEU B 59 CG CD1 CD2 REMARK 470 VAL B 60 CG1 CG2 REMARK 470 LYS B 63 CG CD CE NZ REMARK 470 GLU B 64 CG CD OE1 OE2 REMARK 470 ASN B 67 CG OD1 ND2 REMARK 470 LYS B 72 CG CD CE NZ REMARK 470 LEU B 74 CG CD1 CD2 REMARK 470 ASP B 75 CG OD1 OD2 REMARK 470 GLN B 77 CG CD OE1 NE2 REMARK 470 LYS B 78 CG CD CE NZ REMARK 470 VAL B 79 CG1 CG2 REMARK 470 LYS B 81 CG CD CE NZ REMARK 470 LEU B 82 CG CD1 CD2 REMARK 470 LYS B 83 CG CD CE NZ REMARK 470 ILE B 85 CG1 CG2 CD1 REMARK 470 GLU B 86 CG CD OE1 OE2 REMARK 470 HIS B 87 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 109 OG REMARK 470 SER B 114 OG REMARK 470 HIS B 131 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 133 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 135 CD1 REMARK 470 SER B 139 OG REMARK 470 ILE B 150 CD1 REMARK 470 LEU B 173 CG CD1 CD2 REMARK 470 LEU B 198 CG CD1 CD2 REMARK 470 ILE B 210 CD1 REMARK 470 SER B 212 OG REMARK 470 LYS B 213 CG CD CE NZ REMARK 470 GLN B 242 CG CD OE1 NE2 REMARK 470 ILE B 244 CG1 CG2 CD1 REMARK 470 GLN B 245 CG CD OE1 NE2 REMARK 470 ILE B 246 CD1 REMARK 470 GLU B 248 CG CD OE1 OE2 REMARK 470 LYS B 249 CG CD CE NZ REMARK 470 ILE B 250 CD1 REMARK 470 SER B 252 OG REMARK 470 LYS B 254 CG CD CE NZ REMARK 470 VAL B 255 CG1 CG2 REMARK 470 SER B 263 OG REMARK 470 VAL B 275 CG1 CG2 REMARK 470 THR B 278 OG1 CG2 REMARK 470 ASN B 283 CG OD1 ND2 REMARK 470 LEU B 284 CG CD1 CD2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 ASN B 286 CG OD1 ND2 REMARK 470 ILE B 303 CD1 REMARK 470 LYS B 309 CG CD CE NZ REMARK 470 GLU B 311 CG CD OE1 OE2 REMARK 470 ILE B 315 CD1 REMARK 470 LYS B 317 CG CD CE NZ REMARK 470 PHE B 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 319 CG CD CE NZ REMARK 470 PRO B 321 CG CD REMARK 470 THR B 324 OG1 CG2 REMARK 470 ILE B 335 CG1 CG2 CD1 REMARK 470 ARG B 336 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 339 CG1 CG2 CD1 REMARK 470 ASN B 340 CG OD1 ND2 REMARK 470 GLU B 341 CG CD OE1 OE2 REMARK 470 LYS B 342 CG CD CE NZ REMARK 470 LYS B 345 CG CD CE NZ REMARK 470 GLU B 346 CG CD OE1 OE2 REMARK 470 GLU B 349 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 10 -103.09 -37.85 REMARK 500 GLN A 12 31.11 -92.84 REMARK 500 SER A 14 4.88 -64.94 REMARK 500 ASN A 36 68.84 38.24 REMARK 500 ASP A 41 18.15 -69.52 REMARK 500 ARG A 45 98.38 -62.74 REMARK 500 HIS A 62 103.47 -59.76 REMARK 500 GLU A 64 -74.73 -63.11 REMARK 500 ASN A 99 103.40 -164.61 REMARK 500 PRO A 101 -36.93 -39.46 REMARK 500 ASP A 112 -147.43 -153.84 REMARK 500 ASP A 166 30.59 -166.11 REMARK 500 ASP A 184 90.29 66.16 REMARK 500 LEU A 211 35.39 -71.95 REMARK 500 SER A 212 35.09 21.77 REMARK 500 ALA A 240 -148.75 -130.73 REMARK 500 SER A 259 -30.29 -39.51 REMARK 500 LEU A 277 -5.78 -58.36 REMARK 500 ASN A 283 42.31 -108.54 REMARK 500 HIS A 294 136.42 -39.17 REMARK 500 ARG A 308 35.14 70.20 REMARK 500 PHE A 314 158.07 178.81 REMARK 500 GLU A 331 -159.05 -66.83 REMARK 500 VAL A 337 77.04 -102.47 REMARK 500 SEP A 338 157.72 -36.27 REMARK 500 PHE A 347 50.83 -109.08 REMARK 500 GLN B 12 33.07 -99.40 REMARK 500 SER B 14 5.95 -65.39 REMARK 500 ASN B 36 65.33 37.86 REMARK 500 ALA B 38 -179.33 -176.91 REMARK 500 ASP B 41 17.16 -68.06 REMARK 500 ARG B 45 98.92 -66.95 REMARK 500 GLU B 64 -76.63 -61.97 REMARK 500 ASN B 99 104.15 -164.18 REMARK 500 ASP B 112 -147.50 -154.44 REMARK 500 ARG B 165 48.86 38.54 REMARK 500 ASP B 166 29.44 -167.01 REMARK 500 ASP B 184 90.08 66.18 REMARK 500 LEU B 211 35.94 -72.84 REMARK 500 SER B 212 35.41 21.72 REMARK 500 LEU B 284 -179.38 -66.70 REMARK 500 ARG B 308 33.95 70.81 REMARK 500 PHE B 314 157.00 179.08 REMARK 500 PHE B 318 56.93 -64.13 REMARK 500 PHE B 347 42.83 -102.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MPD B 352 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1L3R RELATED DB: PDB REMARK 900 THE SAME CATALYTIC SUBUNIT WITH ADP, ALUMINUM FLUORIDE, MAGNESIUM REMARK 900 IONS, AND SUBSTRATE PEPTIDE - A CLOSED CONFORMATION REMARK 900 RELATED ID: 1CTP RELATED DB: PDB REMARK 900 MAMMALIAN CATALYTIC SUBUNIT (FROM PORCINE) WITH IODINATED PEPTIDE REMARK 900 BOUND - AN OPEN CONFORMATION REMARK 900 RELATED ID: 1CMK RELATED DB: PDB REMARK 900 MAMMALIAN CATALYTIC SUBUNIT (FROM PORCINE) WITH IODINATED PEPTIDE REMARK 900 BOUND AND A MYRISTIC ACID COVALENTLY ATTACHED - AN OPEN CONFORMATION REMARK 900 RELATED ID: 1ATP RELATED DB: PDB REMARK 900 CATALYTIC SUBUNIT WITH ATP, MAGNESIUM IONS, AND PEPTIDE INHIBITOR - REMARK 900 A CLOSED CONFORMATION REMARK 900 RELATED ID: 1BKX RELATED DB: PDB REMARK 900 CATALYTIC SUBUNIT WITH ADENOSINE - AN INTERMEDIATE CONFORMATION DBREF 1J3H A 1 350 UNP P05132 KAPCA_MOUSE 1 350 DBREF 1J3H B 1 350 UNP P05132 KAPCA_MOUSE 1 350 SEQADV 1J3H TPO A 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 1J3H CME A 199 UNP P05132 CYS 199 MODIFIED RESIDUE SEQADV 1J3H SEP A 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQADV 1J3H TPO B 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 1J3H CME B 199 UNP P05132 CYS 199 MODIFIED RESIDUE SEQADV 1J3H SEP B 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQRES 1 A 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 A 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 A 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 A 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 A 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 A 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 A 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 A 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 A 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 A 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 A 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 A 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 A 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 A 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 A 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 A 350 TRP TPO LEU CME GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 A 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 A 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 A 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 A 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 A 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 A 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 A 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 A 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 A 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 A 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 A 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 B 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 B 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 B 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 B 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 B 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 B 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 B 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 B 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 B 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 B 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 B 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 B 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 B 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 B 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 B 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 B 350 TRP TPO LEU CME GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 B 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 B 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 B 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 B 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 B 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 B 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 B 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 B 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 B 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 B 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 B 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE MODRES 1J3H TPO A 197 THR PHOSPHOTHREONINE MODRES 1J3H CME A 199 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1J3H SEP A 338 SER PHOSPHOSERINE MODRES 1J3H TPO B 197 THR PHOSPHOTHREONINE MODRES 1J3H CME B 199 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1J3H SEP B 338 SER PHOSPHOSERINE HET TPO A 197 11 HET CME A 199 10 HET SEP A 338 10 HET TPO B 197 11 HET CME B 199 10 HET SEP B 338 10 HET MPD A 351 8 HET MPD B 352 8 HETNAM TPO PHOSPHOTHREONINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SEP PHOSPHOSERINE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 MPD 2(C6 H14 O2) HELIX 1 1 GLU A 17 THR A 32 1 16 HELIX 2 2 GLN A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 VAL A 98 1 15 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 GLY A 253 1 12 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 HIS A 294 1 7 HELIX 14 14 LYS A 295 ALA A 298 5 4 HELIX 15 15 ASP A 301 ARG A 308 1 8 HELIX 16 16 VAL B 15 THR B 32 1 18 HELIX 17 17 GLN B 39 ASP B 41 5 3 HELIX 18 18 LYS B 76 LEU B 82 1 7 HELIX 19 19 GLN B 84 VAL B 98 1 15 HELIX 20 20 GLU B 127 GLY B 136 1 10 HELIX 21 21 SER B 139 LEU B 160 1 22 HELIX 22 22 LYS B 168 GLU B 170 5 3 HELIX 23 23 THR B 201 LEU B 205 5 5 HELIX 24 24 ALA B 206 LEU B 211 1 6 HELIX 25 25 LYS B 217 GLY B 234 1 18 HELIX 26 26 GLN B 242 GLY B 253 1 12 HELIX 27 27 SER B 262 LEU B 273 1 12 HELIX 28 28 ASP B 276 ARG B 280 5 5 HELIX 29 29 VAL B 288 HIS B 294 1 7 HELIX 30 30 LYS B 295 ALA B 298 5 4 HELIX 31 31 ASP B 301 ARG B 308 1 8 SHEET 1 A 5 PHE A 43 THR A 51 0 SHEET 2 A 5 ARG A 56 HIS A 62 -1 O VAL A 57 N GLY A 50 SHEET 3 A 5 ASN A 67 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O MET A 118 N LYS A 72 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N PHE A 110 O TYR A 117 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 SHEET 1 D 5 PHE B 43 ASP B 44 0 SHEET 2 D 5 LEU B 59 HIS B 62 -1 O LYS B 61 N ASP B 44 SHEET 3 D 5 HIS B 68 ASP B 75 -1 O TYR B 69 N VAL B 60 SHEET 4 D 5 ASN B 115 GLU B 121 -1 O LEU B 116 N LEU B 74 SHEET 5 D 5 LEU B 106 LYS B 111 -1 N PHE B 108 O VAL B 119 SHEET 1 E 2 LEU B 162 ILE B 163 0 SHEET 2 E 2 LYS B 189 ARG B 190 -1 O LYS B 189 N ILE B 163 SHEET 1 F 2 LEU B 172 ILE B 174 0 SHEET 2 F 2 ILE B 180 VAL B 182 -1 O GLN B 181 N LEU B 173 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C LEU A 198 N CME A 199 1555 1555 1.33 LINK C CME A 199 N GLY A 200 1555 1555 1.32 LINK C VAL A 337 N SEP A 338 1555 1555 1.34 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 LINK C TRP B 196 N TPO B 197 1555 1555 1.34 LINK C TPO B 197 N LEU B 198 1555 1555 1.33 LINK C LEU B 198 N CME B 199 1555 1555 1.33 LINK C CME B 199 N GLY B 200 1555 1555 1.33 LINK C VAL B 337 N SEP B 338 1555 1555 1.34 LINK C SEP B 338 N ILE B 339 1555 1555 1.34 SITE 1 AC1 6 VAL A 15 PHE A 18 PHE A 100 GLU A 155 SITE 2 AC1 6 LYS A 292 TYR A 306 SITE 1 AC2 1 TYR B 306 CRYST1 48.776 143.601 62.809 90.00 105.71 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020502 0.000000 0.005767 0.00000 SCALE2 0.000000 0.006964 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016539 0.00000